This research report provides a comprehensive analysis of the Retinal Drugs and Biologics market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Retinal Drugs and Biologics market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Retinal Drugs and Biologics, challenges faced by the industry, and potential opportunities for market players.
The global Retinal Drugs and Biologics market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Retinal Drugs and Biologics market presents opportunities for various stakeholders, including Hospitals, Clinics. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Retinal Drugs and Biologics market. Additionally, the growing consumer demand present avenues for market expansion.
The global Retinal Drugs and Biologics market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Retinal Drugs and Biologics market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Retinal Drugs and Biologics market.
Market Overview: The report provides a comprehensive overview of the Retinal Drugs and Biologics market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Age Related Macular Degeneration, Diabetic Retinopathy), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Retinal Drugs and Biologics market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Retinal Drugs and Biologics market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Retinal Drugs and Biologics market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Retinal Drugs and Biologics market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Retinal Drugs and Biologics market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Retinal Drugs and Biologics market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Retinal Drugs and Biologics, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Retinal Drugs and Biologics market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- Retinal Drugs and Biologics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Age Related Macular Degeneration
- Diabetic Retinopathy
- Ocular Inflammatory Disease (Uveitis)
- Macular Hole
Market segment by Application
Global Retinal Drugs and Biologics Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- ALLERGAN
- AbbVie
- Alimera Sciences
- Janssen Biotech
- Swedish Orphan Biovitrum
- Roche
- Bristol-Myers Squibb
- Genzyme
- Genentech
- OCULAR THERAPEUTIX
- Bausch & Lomb
- UCBCares
Outline of Major Chapters:
Chapter 1: Introduces the definition of Retinal Drugs and Biologics, market overview.
Chapter 2: Global Retinal Drugs and Biologics market size in revenue and volume.
Chapter 3: Detailed analysis of Retinal Drugs and Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Retinal Drugs and Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Retinal Drugs and Biologics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Retinal Drugs and Biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Retinal Drugs and Biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Retinal Drugs and Biologics Overall Market Size
2.1 Global Retinal Drugs and Biologics Market Size: 2023 VS 2030
2.2 Global Retinal Drugs and Biologics Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Retinal Drugs and Biologics Sales: 2019-2030
3 Company Landscape
3.1 Top Retinal Drugs and Biologics Players in Global Market
3.2 Top Global Retinal Drugs and Biologics Companies Ranked by Revenue
3.3 Global Retinal Drugs and Biologics Revenue by Companies
3.4 Global Retinal Drugs and Biologics Sales by Companies
3.5 Global Retinal Drugs and Biologics Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Retinal Drugs and Biologics Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Retinal Drugs and Biologics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Retinal Drugs and Biologics Players in Global Market
3.8.1 List of Global Tier 1 Retinal Drugs and Biologics Companies
3.8.2 List of Global Tier 2 and Tier 3 Retinal Drugs and Biologics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Retinal Drugs and Biologics Market Size Markets, 2023 & 2030
4.1.2 Age Related Macular Degeneration
4.1.3 Diabetic Retinopathy
4.1.4 Ocular Inflammatory Disease (Uveitis)
4.1.5 Macular Hole
4.2 By Type - Global Retinal Drugs and Biologics Revenue & Forecasts
4.2.1 By Type - Global Retinal Drugs and Biologics Revenue, 2019-2024
4.2.2 By Type - Global Retinal Drugs and Biologics Revenue, 2025-2030
4.2.3 By Type - Global Retinal Drugs and Biologics Revenue Market Share, 2019-2030
4.3 By Type - Global Retinal Drugs and Biologics Sales & Forecasts
4.3.1 By Type - Global Retinal Drugs and Biologics Sales, 2019-2024
4.3.2 By Type - Global Retinal Drugs and Biologics Sales, 2025-2030
4.3.3 By Type - Global Retinal Drugs and Biologics Sales Market Share, 2019-2030
4.4 By Type - Global Retinal Drugs and Biologics Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Retinal Drugs and Biologics Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Retinal Drugs and Biologics Revenue & Forecasts
5.2.1 By Application - Global Retinal Drugs and Biologics Revenue, 2019-2024
5.2.2 By Application - Global Retinal Drugs and Biologics Revenue, 2025-2030
5.2.3 By Application - Global Retinal Drugs and Biologics Revenue Market Share, 2019-2030
5.3 By Application - Global Retinal Drugs and Biologics Sales & Forecasts
5.3.1 By Application - Global Retinal Drugs and Biologics Sales, 2019-2024
5.3.2 By Application - Global Retinal Drugs and Biologics Sales, 2025-2030
5.3.3 By Application - Global Retinal Drugs and Biologics Sales Market Share, 2019-2030
5.4 By Application - Global Retinal Drugs and Biologics Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Retinal Drugs and Biologics Market Size, 2023 & 2030
6.2 By Region - Global Retinal Drugs and Biologics Revenue & Forecasts
6.2.1 By Region - Global Retinal Drugs and Biologics Revenue, 2019-2024
6.2.2 By Region - Global Retinal Drugs and Biologics Revenue, 2025-2030
6.2.3 By Region - Global Retinal Drugs and Biologics Revenue Market Share, 2019-2030
6.3 By Region - Global Retinal Drugs and Biologics Sales & Forecasts
6.3.1 By Region - Global Retinal Drugs and Biologics Sales, 2019-2024
6.3.2 By Region - Global Retinal Drugs and Biologics Sales, 2025-2030
6.3.3 By Region - Global Retinal Drugs and Biologics Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Retinal Drugs and Biologics Revenue, 2019-2030
6.4.2 By Country - North America Retinal Drugs and Biologics Sales, 2019-2030
6.4.3 US Retinal Drugs and Biologics Market Size, 2019-2030
6.4.4 Canada Retinal Drugs and Biologics Market Size, 2019-2030
6.4.5 Mexico Retinal Drugs and Biologics Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Retinal Drugs and Biologics Revenue, 2019-2030
6.5.2 By Country - Europe Retinal Drugs and Biologics Sales, 2019-2030
6.5.3 Germany Retinal Drugs and Biologics Market Size, 2019-2030
6.5.4 France Retinal Drugs and Biologics Market Size, 2019-2030
6.5.5 U.K. Retinal Drugs and Biologics Market Size, 2019-2030
6.5.6 Italy Retinal Drugs and Biologics Market Size, 2019-2030
6.5.7 Russia Retinal Drugs and Biologics Market Size, 2019-2030
6.5.8 Nordic Countries Retinal Drugs and Biologics Market Size, 2019-2030
6.5.9 Benelux Retinal Drugs and Biologics Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Retinal Drugs and Biologics Revenue, 2019-2030
6.6.2 By Region - Asia Retinal Drugs and Biologics Sales, 2019-2030
6.6.3 China Retinal Drugs and Biologics Market Size, 2019-2030
6.6.4 Japan Retinal Drugs and Biologics Market Size, 2019-2030
6.6.5 South Korea Retinal Drugs and Biologics Market Size, 2019-2030
6.6.6 Southeast Asia Retinal Drugs and Biologics Market Size, 2019-2030
6.6.7 India Retinal Drugs and Biologics Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Retinal Drugs and Biologics Revenue, 2019-2030
6.7.2 By Country - South America Retinal Drugs and Biologics Sales, 2019-2030
6.7.3 Brazil Retinal Drugs and Biologics Market Size, 2019-2030
6.7.4 Argentina Retinal Drugs and Biologics Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Retinal Drugs and Biologics Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Retinal Drugs and Biologics Sales, 2019-2030
6.8.3 Turkey Retinal Drugs and Biologics Market Size, 2019-2030
6.8.4 Israel Retinal Drugs and Biologics Market Size, 2019-2030
6.8.5 Saudi Arabia Retinal Drugs and Biologics Market Size, 2019-2030
6.8.6 UAE Retinal Drugs and Biologics Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 ALLERGAN
7.1.1 ALLERGAN Company Summary
7.1.2 ALLERGAN Business Overview
7.1.3 ALLERGAN Retinal Drugs and Biologics Major Product Offerings
7.1.4 ALLERGAN Retinal Drugs and Biologics Sales and Revenue in Global (2019-2024)
7.1.5 ALLERGAN Key News & Latest Developments
7.2 AbbVie
7.2.1 AbbVie Company Summary
7.2.2 AbbVie Business Overview
7.2.3 AbbVie Retinal Drugs and Biologics Major Product Offerings
7.2.4 AbbVie Retinal Drugs and Biologics Sales and Revenue in Global (2019-2024)
7.2.5 AbbVie Key News & Latest Developments
7.3 Alimera Sciences
7.3.1 Alimera Sciences Company Summary
7.3.2 Alimera Sciences Business Overview
7.3.3 Alimera Sciences Retinal Drugs and Biologics Major Product Offerings
7.3.4 Alimera Sciences Retinal Drugs and Biologics Sales and Revenue in Global (2019-2024)
7.3.5 Alimera Sciences Key News & Latest Developments
7.4 Janssen Biotech
7.4.1 Janssen Biotech Company Summary
7.4.2 Janssen Biotech Business Overview
7.4.3 Janssen Biotech Retinal Drugs and Biologics Major Product Offerings
7.4.4 Janssen Biotech Retinal Drugs and Biologics Sales and Revenue in Global (2019-2024)
7.4.5 Janssen Biotech Key News & Latest Developments
7.5 Swedish Orphan Biovitrum
7.5.1 Swedish Orphan Biovitrum Company Summary
7.5.2 Swedish Orphan Biovitrum Business Overview
7.5.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Major Product Offerings
7.5.4 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales and Revenue in Global (2019-2024)
7.5.5 Swedish Orphan Biovitrum Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche Retinal Drugs and Biologics Major Product Offerings
7.6.4 Roche Retinal Drugs and Biologics Sales and Revenue in Global (2019-2024)
7.6.5 Roche Key News & Latest Developments
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Company Summary
7.7.2 Bristol-Myers Squibb Business Overview
7.7.3 Bristol-Myers Squibb Retinal Drugs and Biologics Major Product Offerings
7.7.4 Bristol-Myers Squibb Retinal Drugs and Biologics Sales and Revenue in Global (2019-2024)
7.7.5 Bristol-Myers Squibb Key News & Latest Developments
7.8 Genzyme
7.8.1 Genzyme Company Summary
7.8.2 Genzyme Business Overview
7.8.3 Genzyme Retinal Drugs and Biologics Major Product Offerings
7.8.4 Genzyme Retinal Drugs and Biologics Sales and Revenue in Global (2019-2024)
7.8.5 Genzyme Key News & Latest Developments
7.9 Genentech
7.9.1 Genentech Company Summary
7.9.2 Genentech Business Overview
7.9.3 Genentech Retinal Drugs and Biologics Major Product Offerings
7.9.4 Genentech Retinal Drugs and Biologics Sales and Revenue in Global (2019-2024)
7.9.5 Genentech Key News & Latest Developments
7.10 OCULAR THERAPEUTIX
7.10.1 OCULAR THERAPEUTIX Company Summary
7.10.2 OCULAR THERAPEUTIX Business Overview
7.10.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Major Product Offerings
7.10.4 OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales and Revenue in Global (2019-2024)
7.10.5 OCULAR THERAPEUTIX Key News & Latest Developments
7.11 Bausch & Lomb
7.11.1 Bausch & Lomb Company Summary
7.11.2 Bausch & Lomb Business Overview
7.11.3 Bausch & Lomb Retinal Drugs and Biologics Major Product Offerings
7.11.4 Bausch & Lomb Retinal Drugs and Biologics Sales and Revenue in Global (2019-2024)
7.11.5 Bausch & Lomb Key News & Latest Developments
7.12 UCBCares
7.12.1 UCBCares Company Summary
7.12.2 UCBCares Business Overview
7.12.3 UCBCares Retinal Drugs and Biologics Major Product Offerings
7.12.4 UCBCares Retinal Drugs and Biologics Sales and Revenue in Global (2019-2024)
7.12.5 UCBCares Key News & Latest Developments
8 Global Retinal Drugs and Biologics Production Capacity, Analysis
8.1 Global Retinal Drugs and Biologics Production Capacity, 2019-2030
8.2 Retinal Drugs and Biologics Production Capacity of Key Manufacturers in Global Market
8.3 Global Retinal Drugs and Biologics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Retinal Drugs and Biologics Supply Chain Analysis
10.1 Retinal Drugs and Biologics Industry Value Chain
10.2 Retinal Drugs and Biologics Upstream Market
10.3 Retinal Drugs and Biologics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Retinal Drugs and Biologics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Retinal Drugs and Biologics in Global Market
Table 2. Top Retinal Drugs and Biologics Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Retinal Drugs and Biologics Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Retinal Drugs and Biologics Revenue Share by Companies, 2019-2024
Table 5. Global Retinal Drugs and Biologics Sales by Companies, (K MT), 2019-2024
Table 6. Global Retinal Drugs and Biologics Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Retinal Drugs and Biologics Price (2019-2024) & (USD/MT)
Table 8. Global Manufacturers Retinal Drugs and Biologics Product Type
Table 9. List of Global Tier 1 Retinal Drugs and Biologics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Retinal Drugs and Biologics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Retinal Drugs and Biologics Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Retinal Drugs and Biologics Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Retinal Drugs and Biologics Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Retinal Drugs and Biologics Sales (K MT), 2019-2024
Table 15. By Type - Global Retinal Drugs and Biologics Sales (K MT), 2025-2030
Table 16. By Application ? Global Retinal Drugs and Biologics Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Retinal Drugs and Biologics Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Retinal Drugs and Biologics Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Retinal Drugs and Biologics Sales (K MT), 2019-2024
Table 20. By Application - Global Retinal Drugs and Biologics Sales (K MT), 2025-2030
Table 21. By Region ? Global Retinal Drugs and Biologics Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Retinal Drugs and Biologics Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Retinal Drugs and Biologics Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Retinal Drugs and Biologics Sales (K MT), 2019-2024
Table 25. By Region - Global Retinal Drugs and Biologics Sales (K MT), 2025-2030
Table 26. By Country - North America Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Retinal Drugs and Biologics Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Retinal Drugs and Biologics Sales, (K MT), 2019-2024
Table 29. By Country - North America Retinal Drugs and Biologics Sales, (K MT), 2025-2030
Table 30. By Country - Europe Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Retinal Drugs and Biologics Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Retinal Drugs and Biologics Sales, (K MT), 2019-2024
Table 33. By Country - Europe Retinal Drugs and Biologics Sales, (K MT), 2025-2030
Table 34. By Region - Asia Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Retinal Drugs and Biologics Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Retinal Drugs and Biologics Sales, (K MT), 2019-2024
Table 37. By Region - Asia Retinal Drugs and Biologics Sales, (K MT), 2025-2030
Table 38. By Country - South America Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Retinal Drugs and Biologics Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Retinal Drugs and Biologics Sales, (K MT), 2019-2024
Table 41. By Country - South America Retinal Drugs and Biologics Sales, (K MT), 2025-2030
Table 42. By Country - Middle East & Africa Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Retinal Drugs and Biologics Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Retinal Drugs and Biologics Sales, (K MT), 2019-2024
Table 45. By Country - Middle East & Africa Retinal Drugs and Biologics Sales, (K MT), 2025-2030
Table 46. ALLERGAN Company Summary
Table 47. ALLERGAN Retinal Drugs and Biologics Product Offerings
Table 48. ALLERGAN Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 49. ALLERGAN Key News & Latest Developments
Table 50. AbbVie Company Summary
Table 51. AbbVie Retinal Drugs and Biologics Product Offerings
Table 52. AbbVie Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 53. AbbVie Key News & Latest Developments
Table 54. Alimera Sciences Company Summary
Table 55. Alimera Sciences Retinal Drugs and Biologics Product Offerings
Table 56. Alimera Sciences Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 57. Alimera Sciences Key News & Latest Developments
Table 58. Janssen Biotech Company Summary
Table 59. Janssen Biotech Retinal Drugs and Biologics Product Offerings
Table 60. Janssen Biotech Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 61. Janssen Biotech Key News & Latest Developments
Table 62. Swedish Orphan Biovitrum Company Summary
Table 63. Swedish Orphan Biovitrum Retinal Drugs and Biologics Product Offerings
Table 64. Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 65. Swedish Orphan Biovitrum Key News & Latest Developments
Table 66. Roche Company Summary
Table 67. Roche Retinal Drugs and Biologics Product Offerings
Table 68. Roche Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 69. Roche Key News & Latest Developments
Table 70. Bristol-Myers Squibb Company Summary
Table 71. Bristol-Myers Squibb Retinal Drugs and Biologics Product Offerings
Table 72. Bristol-Myers Squibb Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 73. Bristol-Myers Squibb Key News & Latest Developments
Table 74. Genzyme Company Summary
Table 75. Genzyme Retinal Drugs and Biologics Product Offerings
Table 76. Genzyme Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 77. Genzyme Key News & Latest Developments
Table 78. Genentech Company Summary
Table 79. Genentech Retinal Drugs and Biologics Product Offerings
Table 80. Genentech Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 81. Genentech Key News & Latest Developments
Table 82. OCULAR THERAPEUTIX Company Summary
Table 83. OCULAR THERAPEUTIX Retinal Drugs and Biologics Product Offerings
Table 84. OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 85. OCULAR THERAPEUTIX Key News & Latest Developments
Table 86. Bausch & Lomb Company Summary
Table 87. Bausch & Lomb Retinal Drugs and Biologics Product Offerings
Table 88. Bausch & Lomb Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 89. Bausch & Lomb Key News & Latest Developments
Table 90. UCBCares Company Summary
Table 91. UCBCares Retinal Drugs and Biologics Product Offerings
Table 92. UCBCares Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 93. UCBCares Key News & Latest Developments
Table 94. Retinal Drugs and Biologics Production Capacity (K MT) of Key Manufacturers in Global Market, 2022-2024 (K MT)
Table 95. Global Retinal Drugs and Biologics Capacity Market Share of Key Manufacturers, 2022-2024
Table 96. Global Retinal Drugs and Biologics Production by Region, 2019-2024 (K MT)
Table 97. Global Retinal Drugs and Biologics Production by Region, 2025-2030 (K MT)
Table 98. Retinal Drugs and Biologics Market Opportunities & Trends in Global Market
Table 99. Retinal Drugs and Biologics Market Drivers in Global Market
Table 100. Retinal Drugs and Biologics Market Restraints in Global Market
Table 101. Retinal Drugs and Biologics Raw Materials
Table 102. Retinal Drugs and Biologics Raw Materials Suppliers in Global Market
Table 103. Typical Retinal Drugs and Biologics Downstream
Table 104. Retinal Drugs and Biologics Downstream Clients in Global Market
Table 105. Retinal Drugs and Biologics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Retinal Drugs and Biologics Segment by Type in 2023
Figure 2. Retinal Drugs and Biologics Segment by Application in 2023
Figure 3. Global Retinal Drugs and Biologics Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Retinal Drugs and Biologics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Retinal Drugs and Biologics Revenue, 2019-2030 (US$, Mn)
Figure 7. Retinal Drugs and Biologics Sales in Global Market: 2019-2030 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Retinal Drugs and Biologics Revenue in 2023
Figure 9. By Type - Global Retinal Drugs and Biologics Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Retinal Drugs and Biologics Revenue Market Share, 2019-2030
Figure 11. By Type - Global Retinal Drugs and Biologics Sales Market Share, 2019-2030
Figure 12. By Type - Global Retinal Drugs and Biologics Price (USD/MT), 2019-2030
Figure 13. By Application - Global Retinal Drugs and Biologics Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Retinal Drugs and Biologics Revenue Market Share, 2019-2030
Figure 15. By Application - Global Retinal Drugs and Biologics Sales Market Share, 2019-2030
Figure 16. By Application - Global Retinal Drugs and Biologics Price (USD/MT), 2019-2030
Figure 17. By Region - Global Retinal Drugs and Biologics Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Retinal Drugs and Biologics Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Retinal Drugs and Biologics Revenue Market Share, 2019-2030
Figure 20. By Region - Global Retinal Drugs and Biologics Sales Market Share, 2019-2030
Figure 21. By Country - North America Retinal Drugs and Biologics Revenue Market Share, 2019-2030
Figure 22. By Country - North America Retinal Drugs and Biologics Sales Market Share, 2019-2030
Figure 23. US Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Retinal Drugs and Biologics Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Retinal Drugs and Biologics Sales Market Share, 2019-2030
Figure 28. Germany Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 29. France Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Retinal Drugs and Biologics Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Retinal Drugs and Biologics Sales Market Share, 2019-2030
Figure 37. China Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 41. India Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Retinal Drugs and Biologics Revenue Market Share, 2019-2030
Figure 43. By Country - South America Retinal Drugs and Biologics Sales Market Share, 2019-2030
Figure 44. Brazil Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Retinal Drugs and Biologics Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Retinal Drugs and Biologics Sales Market Share, 2019-2030
Figure 48. Turkey Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Retinal Drugs and Biologics Revenue, (US$, Mn), 2019-2030
Figure 52. Global Retinal Drugs and Biologics Production Capacity (K MT), 2019-2030
Figure 53. The Percentage of Production Retinal Drugs and Biologics by Region, 2023 VS 2030
Figure 54. Retinal Drugs and Biologics Industry Value Chain
Figure 55. Marketing Channels
